UY33181A - Derivados de oxazolopirimidina 2,5-sustituidos. - Google Patents

Derivados de oxazolopirimidina 2,5-sustituidos.

Info

Publication number
UY33181A
UY33181A UY0001033181A UY33181A UY33181A UY 33181 A UY33181 A UY 33181A UY 0001033181 A UY0001033181 A UY 0001033181A UY 33181 A UY33181 A UY 33181A UY 33181 A UY33181 A UY 33181A
Authority
UY
Uruguay
Prior art keywords
oxazolopirimidine
substituted derivatives
formula
compounds
healing
Prior art date
Application number
UY0001033181A
Other languages
English (en)
Inventor
Dr Axel Dietrich
Dr Stephanie Hachtel
Dr Katrin Hiss
Dr Thomas Huebschle
Dr Dieter Kadereit
Dr Matthias Schaefer
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY33181A publication Critical patent/UY33181A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La presente invención se refiere a compuestos de oxazolopirimidina de fórmula I, en la que A, R1 y R2 se definen como se ha indicado en las reivindicaciones. Los compuestos de la fórmula I son adecuados, por ejemplo, para la cicatrización.
UY0001033181A 2010-01-14 2011-01-12 Derivados de oxazolopirimidina 2,5-sustituidos. UY33181A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10305044 2010-01-14

Publications (1)

Publication Number Publication Date
UY33181A true UY33181A (es) 2011-08-31

Family

ID=41800382

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033181A UY33181A (es) 2010-01-14 2011-01-12 Derivados de oxazolopirimidina 2,5-sustituidos.

Country Status (21)

Country Link
US (1) US9040544B2 (es)
EP (1) EP2523963B1 (es)
JP (1) JP5841069B2 (es)
KR (1) KR101764607B1 (es)
CN (1) CN102834400B (es)
AR (1) AR079885A1 (es)
AU (1) AU2011206617B2 (es)
BR (1) BR112012017484A2 (es)
CA (1) CA2784565C (es)
DK (1) DK2523963T3 (es)
ES (1) ES2524712T3 (es)
HK (1) HK1178887A1 (es)
IL (1) IL220719A (es)
MX (1) MX2012007837A (es)
MY (1) MY159857A (es)
PT (1) PT2523963E (es)
RU (1) RU2554874C2 (es)
SG (1) SG182483A1 (es)
TW (1) TWI544926B (es)
UY (1) UY33181A (es)
WO (1) WO2011086081A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY33177A (es) 2010-01-13 2011-08-31 Sanofi Aventis Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
AR079980A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
AR079884A1 (es) * 2010-01-14 2012-02-29 Sanofi Aventis Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida
CA2784560C (en) * 2010-01-14 2017-12-05 Sanofi Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
US9321787B2 (en) 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679682A (en) * 1970-04-23 1972-07-25 Fmc Corp CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES
EP1622913A1 (en) * 2003-04-25 2006-02-08 University College Cardiff Consultants, Ltd. Heterocyclic compounds for use in the treatment of viral infections
JP4638410B2 (ja) * 2003-04-30 2011-02-23 ノバルティス アーゲー スフィンゴシン−１−ホスフェートレセプターモジュレーターとしての、アミノプロパノール誘導体
JP4575920B2 (ja) * 2003-05-19 2010-11-04 アイアールエム・リミテッド・ライアビリティ・カンパニー 免疫抑制化合物および組成物
CA2524048C (en) * 2003-05-19 2013-06-25 Irm Llc Immunosuppressant compounds and compositions
MX2008002540A (es) * 2005-08-23 2008-03-14 Irm Llc Compuestos inmunosupresores y composiciones.
US7919519B2 (en) * 2005-11-23 2011-04-05 Epix Pharmaceuticals Inc. S1P receptor modulating compounds and use thereof
AU2006317689B2 (en) 2005-11-23 2013-07-25 Epix Delaware, Inc. S1P receptor modulating compounds and use thereof
CA2679980A1 (en) * 2007-03-21 2007-09-27 Epix Pharmaceuticals, Inc. S1p receptor modulating compounds and use thereof
WO2009013545A2 (en) * 2007-07-26 2009-01-29 Astrazeneca Ab Chemical compounds
US7863291B2 (en) * 2008-04-23 2011-01-04 Bristol-Myers Squibb Company Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
TW201000099A (en) * 2008-06-20 2010-01-01 Amgen Inc S1P1 receptor agonists and use thereof
JP5449346B2 (ja) * 2008-07-15 2014-03-19 サノフイ Ｅｄｇ−１受容体アゴニストとしてのオキサゾロピリミジン類
UY33177A (es) * 2010-01-13 2011-08-31 Sanofi Aventis Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
AR079982A1 (es) * 2010-01-13 2012-03-07 Sanofi Aventis Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5,7- sustituido., composiciones farmaceuticas y procesos para prepararlos.
AR079980A1 (es) * 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
AR079884A1 (es) * 2010-01-14 2012-02-29 Sanofi Aventis Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida
CA2784560C (en) * 2010-01-14 2017-12-05 Sanofi Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring

Also Published As

Publication number Publication date
TWI544926B (zh) 2016-08-11
AU2011206617A1 (en) 2012-08-02
RU2554874C2 (ru) 2015-06-27
WO2011086081A1 (de) 2011-07-21
BR112012017484A2 (pt) 2020-08-25
JP5841069B2 (ja) 2016-01-06
US20130072501A1 (en) 2013-03-21
CN102834400B (zh) 2015-06-10
AU2011206617B2 (en) 2015-07-16
IL220719A (en) 2015-03-31
CA2784565A1 (en) 2011-07-21
EP2523963A1 (de) 2012-11-21
MX2012007837A (es) 2012-07-30
US9040544B2 (en) 2015-05-26
KR20120115403A (ko) 2012-10-17
CN102834400A (zh) 2012-12-19
ES2524712T3 (es) 2014-12-11
EP2523963B1 (de) 2014-08-27
KR101764607B1 (ko) 2017-08-03
DK2523963T3 (en) 2014-12-01
AR079885A1 (es) 2012-02-29
PT2523963E (pt) 2014-11-06
JP2013517243A (ja) 2013-05-16
CA2784565C (en) 2018-03-13
RU2012134636A (ru) 2014-02-20
MY159857A (en) 2017-02-15
HK1178887A1 (en) 2013-09-19
TW201134473A (en) 2011-10-16
SG182483A1 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
UY33199A (es) 5-alquinil-pirimidinas.
CU20120099A7 (es) Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
CO6450612A2 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
BR112012033350A2 (pt) "composição e métodos para modular a via de sinalização de wnt"
ECSP11011079A (es) Nuevos compuestos de hidroxiareno.
SV2011003855A (es) Heteroarilos sustituidos
ECSP11011244A (es) Nuevos herbicidas.
DOP2014000033A (es) Aminoquinazolinas como inhibidores de quinasa
UY32494A (es) Nuevas 2,4-diaminopirimidinas, sales farmacéuticas de las mismas, composiciones conteniéndolas y aplicaciones
UY32553A (es) Nuevos derivados de la pirrolidinadiona espiroheterocíclicos 3-sustituidos
ECSP11011218A (es) Herbicidas derivados de ciclopentanodiona.
ECSP11011245A (es) Novedosos herbicidas
UY32009A (es) 5-alquinil-pirimidinas
CR20150171A (es) Benzamidas
UY33176A (es) Derivados de oxazolopirimidina sustituida en 2, 5, 7.
ECSP11010816A (es) Nuevos Compuestos
ECSP11011485A (es) Espiro-epóxidos como productos intermedios.
UY33181A (es) Derivados de oxazolopirimidina 2,5-sustituidos.
UY33180A (es) Derivados de ácido carboxílico heterocíclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida.
UY33179A (es) Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2,5-sustituido.
UY33177A (es) Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
CO6460762A2 (es) 5-alquinil-piridinas
UY33092A (es) Compuestos de triazol, su uso y agentes que los contienen
UY32101A (es) Compuestos de triazol, su uso, así como productos que los contienen

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20191121